Latest Pharma and Biotech News
Biotechnology
11 March 2025 Shares of US biotech 2seventy Bio skyrocketed almost 76% to $4.92 today, as it agreed to a takeover bid from US pharma major Bristol Myers Squibb, which is looking to enhance its CAR T-cell therapy business.
Today's issue
Refine Search
Biotechnology
USA-based Emergent BioSolutions and Swiss vaccines firm Rocketvax have announced an agreement. 12 March 2025
Pharmaceutical
Specialist HIV company ViiV Healthcare, which is majority owned by UK pharma major GSK, today announced positive findings from the company’s EMBRACE Phase IIb study. 12 March 2025
Pharmaceutical
Japanese drugmaker Ono Pharmaceutical has entered into a license agreement with USA-based Ionis Pharmaceuticals for sapablursen, an investigational RNA-targeted medicine for the treatment of polycythemia vera (PV). Ionis’ shares edged up 2.4% to $33.82 on the news. 12 March 2025
Pharmaceutical
Sweden-based women’s health company Gedea Biotech has completed a clinical trial, the NEFERTITI-2 study, for the treatment of bacterial vaginosis. 12 March 2025
Pharmaceutical
Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, following the implementation of Veeva Systems' Development Cloud. 12 March 2025
Pharmaceutical
ViiV Healthcare has announced promising results from two Phase IIa studies of investigational antiretroviral therapies, VH184 and VH499. 12 March 2025
Pharmaceutical
Shares of Danish biotech Zealand Pharma were up 30% at 635.50 kroner by early afternoon, on news of a potentially lucrative licensing deal with Swiss pharm giant Roche. 12 March 2025
Pharmaceutical
US biopharma Viking Therapeutics developing therapies for metabolic and endocrine disorders, closed Tuesday’s trading 5% lower. 12 March 2025
Pharmaceutical
California commercial-stage biopharma firm Geron Corporation has announced that Dr John “Chip” Scarlett, president, chief executive (CEO) and chairman, will depart the company on March 31, 2025. 12 March 2025
Biotechnology
UK-based Purespring Therapeutics, a pioneering company focused on transforming the treatment of kidney diseases, today announces the appointment of Haseeb Ahmad as its chief executive (CEO) and member of the board of directors effective immediately. 12 March 2025
Biotechnology
Independent French drugmaker Pierre Fabre Laboratories and Switzerland-based RedRidge Bio have announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against multiple targets. 12 March 2025
Biotechnology
Italian biomedical charity Fondazione Telethon, which is focused on rare genetic diseases, revealed it has submitted a Biologics License Application (BLA) for the gene therapy - etuvetidigene autotemcel – as a treatment of patients with Wiskott-Aldrich syndrome (WAS), a rare genetic disease of the immune system, to the US Food and Drug Administration (FDA). 12 March 2025
Generics
Rajeev Juneja, vice chairman and managing director of Mumbai, Indian-based drugmaker Mankind Pharma, today announced that the company is launching the generic version as well as its fixed dose combination (FDCs) of diabetes drug empagliflozin in India, at a 90% discount to the originator, Boehringer Ingelheim’s drug, Jardiance. The news came as empagliflozin lost patent protection in India. 12 March 2025
Pharmaceutical
In this week’s podcast, we welcome Ido Peleg, CEO and Co-Founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. 11 March 2025
Biotechnology
Harbour BioMed has appointed Michael Patten as chief strategy officer, responsible for overseeing global corporate development and growth strategy. He will also lead the company's global alliance efforts, focusing on expanding its presence in key markets outside China. 11 March 2025
Pharmaceutical
Alliance Pharma has accepted a final increased cash offer from investment firm DBAY Advisors, valuing the UK-based pharmaceutical company at approximately £362 million ($468 million). 11 March 2025
Pharmaceutical
USA-based Endo Inc today announced it has entered into a definitive agreement to divest its international pharmaceuticals business, primarily operated through Canada-based specialty pharmaceutical company Paladin Pharma to Knight Therapeutics. 11 March 2025
Biotechnology
Privately-held Tenpoint Therapeutics, a UK-headquartered biotech focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, has announced the appointment of Carol Kearney as chief commercial officer (CCO). 11 March 2025
Biotechnology
Shares of US biotech 2seventy Bio skyrocketed almost 76% to $4.92 today, as it agreed to a takeover bid from US pharma major Bristol Myers Squibb, which is looking to enhance its CAR T-cell therapy business. 11 March 2025
Pharmaceutical
A recent study published in Diabetes Technology & Therapeutics has demonstrated that the off-label use of semaglutide and tirzepatide leads to significant reductions in HbA1c levels and body weight among adults with type 1 diabetes (T1D). 11 March 2025
All news
Biotechnology
USA-based Emergent BioSolutions and Swiss vaccines firm Rocketvax have announced an agreement. 12 March 2025
Pharmaceutical
Specialist HIV company ViiV Healthcare, which is majority owned by UK pharma major GSK, today announced positive findings from the company’s EMBRACE Phase IIb study. 12 March 2025
Pharmaceutical
Japanese drugmaker Ono Pharmaceutical has entered into a license agreement with USA-based Ionis Pharmaceuticals for sapablursen, an investigational RNA-targeted medicine for the treatment of polycythemia vera (PV). Ionis’ shares edged up 2.4% to $33.82 on the news. 12 March 2025
Pharmaceutical
Sweden-based women’s health company Gedea Biotech has completed a clinical trial, the NEFERTITI-2 study, for the treatment of bacterial vaginosis. 12 March 2025
Pharmaceutical
Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, following the implementation of Veeva Systems' Development Cloud. 12 March 2025
Pharmaceutical
ViiV Healthcare has announced promising results from two Phase IIa studies of investigational antiretroviral therapies, VH184 and VH499. 12 March 2025
Pharmaceutical
Shares of Danish biotech Zealand Pharma were up 30% at 635.50 kroner by early afternoon, on news of a potentially lucrative licensing deal with Swiss pharm giant Roche. 12 March 2025
Pharmaceutical
US biopharma Viking Therapeutics developing therapies for metabolic and endocrine disorders, closed Tuesday’s trading 5% lower. 12 March 2025
Pharmaceutical
California commercial-stage biopharma firm Geron Corporation has announced that Dr John “Chip” Scarlett, president, chief executive (CEO) and chairman, will depart the company on March 31, 2025. 12 March 2025
Biotechnology
UK-based Purespring Therapeutics, a pioneering company focused on transforming the treatment of kidney diseases, today announces the appointment of Haseeb Ahmad as its chief executive (CEO) and member of the board of directors effective immediately. 12 March 2025
Biotechnology
Independent French drugmaker Pierre Fabre Laboratories and Switzerland-based RedRidge Bio have announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic antibody (BPA) drug candidates against multiple targets. 12 March 2025
Biotechnology
Italian biomedical charity Fondazione Telethon, which is focused on rare genetic diseases, revealed it has submitted a Biologics License Application (BLA) for the gene therapy - etuvetidigene autotemcel – as a treatment of patients with Wiskott-Aldrich syndrome (WAS), a rare genetic disease of the immune system, to the US Food and Drug Administration (FDA). 12 March 2025
Generics
Rajeev Juneja, vice chairman and managing director of Mumbai, Indian-based drugmaker Mankind Pharma, today announced that the company is launching the generic version as well as its fixed dose combination (FDCs) of diabetes drug empagliflozin in India, at a 90% discount to the originator, Boehringer Ingelheim’s drug, Jardiance. The news came as empagliflozin lost patent protection in India. 12 March 2025
Pharmaceutical
In this week’s podcast, we welcome Ido Peleg, CEO and Co-Founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. 11 March 2025
Biotechnology
Harbour BioMed has appointed Michael Patten as chief strategy officer, responsible for overseeing global corporate development and growth strategy. He will also lead the company's global alliance efforts, focusing on expanding its presence in key markets outside China. 11 March 2025
Pharmaceutical
Alliance Pharma has accepted a final increased cash offer from investment firm DBAY Advisors, valuing the UK-based pharmaceutical company at approximately £362 million ($468 million). 11 March 2025
Pharmaceutical
USA-based Endo Inc today announced it has entered into a definitive agreement to divest its international pharmaceuticals business, primarily operated through Canada-based specialty pharmaceutical company Paladin Pharma to Knight Therapeutics. 11 March 2025
Biotechnology
Privately-held Tenpoint Therapeutics, a UK-headquartered biotech focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, has announced the appointment of Carol Kearney as chief commercial officer (CCO). 11 March 2025
Biotechnology
Shares of US biotech 2seventy Bio skyrocketed almost 76% to $4.92 today, as it agreed to a takeover bid from US pharma major Bristol Myers Squibb, which is looking to enhance its CAR T-cell therapy business. 11 March 2025
Pharmaceutical
A recent study published in Diabetes Technology & Therapeutics has demonstrated that the off-label use of semaglutide and tirzepatide leads to significant reductions in HbA1c levels and body weight among adults with type 1 diabetes (T1D). 11 March 2025
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze